Cargando…

Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany

There is conflicting evidence regarding the efficacy of neoadjuvant/perioperative chemotherapy (NCT) for gastro-esophageal cancer (GEC) on overall survival. This study aimed to analyze the outcomes of multimodal treatments in a large single center cohort. We performed a retrospective analysis of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Schirren, Rebekka, Novotny, Alexander, Friess, Helmut, Reim, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465424/
https://www.ncbi.nlm.nih.gov/pubmed/32796715
http://dx.doi.org/10.3390/cancers12082244
_version_ 1783577584889495552
author Schirren, Rebekka
Novotny, Alexander
Friess, Helmut
Reim, Daniel
author_facet Schirren, Rebekka
Novotny, Alexander
Friess, Helmut
Reim, Daniel
author_sort Schirren, Rebekka
collection PubMed
description There is conflicting evidence regarding the efficacy of neoadjuvant/perioperative chemotherapy (NCT) for gastro-esophageal cancer (GEC) on overall survival. This study aimed to analyze the outcomes of multimodal treatments in a large single center cohort. We performed a retrospective analysis of patients treated with NCT, followed by intended curative oncological surgery for locally advanced gastric cancer. Uni- and multivariate regression analysis were performed to identify the predictors of overall survival. From over 3000 patients, 702 eligible patients were analyzed. In the univariate analysis clinical stage, application of preoperative PLF, requirement of surgical extension, UICC-stage, grading, R-status, Lauren histotype, and HPR were the prognostic survival factors. In multivariate analysis PLF regimen, UICC-stages, R-status, Lauren histotype, and histopathologic regression (HPR) were significant predictors of overall survival. Overall HPR-rate was 26.9%. HPR was highest in the cT2cN0 stage (55.9%), and lowest in the cT3/4 cN+ stage (21.6%). FLOT demonstrated the highest HPR (37.5%). Independent predictors for HPR were the clinical stage and grading. Kaplan Meier analyses demonstrated significant survival benefits for the responding patients (p < 0.0001). HPR after NCT was an important prognostic factor to predict overall survival for locally advanced GEC. FLOT should be the preferred regimen in patients undergoing NCT ahead of surgery.
format Online
Article
Text
id pubmed-7465424
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74654242020-09-04 Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany Schirren, Rebekka Novotny, Alexander Friess, Helmut Reim, Daniel Cancers (Basel) Article There is conflicting evidence regarding the efficacy of neoadjuvant/perioperative chemotherapy (NCT) for gastro-esophageal cancer (GEC) on overall survival. This study aimed to analyze the outcomes of multimodal treatments in a large single center cohort. We performed a retrospective analysis of patients treated with NCT, followed by intended curative oncological surgery for locally advanced gastric cancer. Uni- and multivariate regression analysis were performed to identify the predictors of overall survival. From over 3000 patients, 702 eligible patients were analyzed. In the univariate analysis clinical stage, application of preoperative PLF, requirement of surgical extension, UICC-stage, grading, R-status, Lauren histotype, and HPR were the prognostic survival factors. In multivariate analysis PLF regimen, UICC-stages, R-status, Lauren histotype, and histopathologic regression (HPR) were significant predictors of overall survival. Overall HPR-rate was 26.9%. HPR was highest in the cT2cN0 stage (55.9%), and lowest in the cT3/4 cN+ stage (21.6%). FLOT demonstrated the highest HPR (37.5%). Independent predictors for HPR were the clinical stage and grading. Kaplan Meier analyses demonstrated significant survival benefits for the responding patients (p < 0.0001). HPR after NCT was an important prognostic factor to predict overall survival for locally advanced GEC. FLOT should be the preferred regimen in patients undergoing NCT ahead of surgery. MDPI 2020-08-11 /pmc/articles/PMC7465424/ /pubmed/32796715 http://dx.doi.org/10.3390/cancers12082244 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Schirren, Rebekka
Novotny, Alexander
Friess, Helmut
Reim, Daniel
Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
title Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
title_full Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
title_fullStr Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
title_full_unstemmed Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
title_short Histopathologic Response Is a Positive Predictor of Overall Survival in Patients Undergoing Neoadjuvant/Perioperative Chemotherapy for Locally Advanced Gastric or Gastroesophageal Junction Cancers—Analysis from a Large Single Center Cohort in Germany
title_sort histopathologic response is a positive predictor of overall survival in patients undergoing neoadjuvant/perioperative chemotherapy for locally advanced gastric or gastroesophageal junction cancers—analysis from a large single center cohort in germany
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465424/
https://www.ncbi.nlm.nih.gov/pubmed/32796715
http://dx.doi.org/10.3390/cancers12082244
work_keys_str_mv AT schirrenrebekka histopathologicresponseisapositivepredictorofoverallsurvivalinpatientsundergoingneoadjuvantperioperativechemotherapyforlocallyadvancedgastricorgastroesophagealjunctioncancersanalysisfromalargesinglecentercohortingermany
AT novotnyalexander histopathologicresponseisapositivepredictorofoverallsurvivalinpatientsundergoingneoadjuvantperioperativechemotherapyforlocallyadvancedgastricorgastroesophagealjunctioncancersanalysisfromalargesinglecentercohortingermany
AT friesshelmut histopathologicresponseisapositivepredictorofoverallsurvivalinpatientsundergoingneoadjuvantperioperativechemotherapyforlocallyadvancedgastricorgastroesophagealjunctioncancersanalysisfromalargesinglecentercohortingermany
AT reimdaniel histopathologicresponseisapositivepredictorofoverallsurvivalinpatientsundergoingneoadjuvantperioperativechemotherapyforlocallyadvancedgastricorgastroesophagealjunctioncancersanalysisfromalargesinglecentercohortingermany